Suppr超能文献

一项旨在为新的血管性血友病治疗指南提供优先事项的国际调查。

An international survey to inform priorities for new guidelines on von Willebrand disease.

机构信息

Outcomes and Implementation Research Unit, Department of Nephrology and Hypertension, University of Kansas Medical Center, Kansas City, KS, USA.

Hematology Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

出版信息

Haemophilia. 2020 Jan;26(1):106-116. doi: 10.1111/hae.13881. Epub 2019 Nov 26.

Abstract

INTRODUCTION

von Willebrand disease (VWD) is an inherited bleeding disorder caused by a quantitative or qualitative dysfunction of von Willebrand factor. Clinicians, patients and other stakeholders have many questions about the diagnosis and management of the disease.

AIM

To identify topics of highest importance to stakeholders that could be addressed by guidelines to be developed by the American Society of Hematology (ASH), the International Society on Thrombosis and Haemostasis (ISTH), the National Hemophilia Foundation (NHF) and the World Federation of Hemophilia (WFH).

METHODS

A survey to determine and prioritize topics to be addressed in the collaborative development of guidelines for VWD was distributed to international stakeholders including patients, caregivers and healthcare providers (HCPs). Representatives of the four organizations coordinated the distribution strategy. The survey focused on both diagnosis and management of VWD, soliciting 7-point Likert-scale responses and open-ended comments, in English, French and Spanish. We conducted descriptive analysis with comparison of results by stakeholder type, gender and countries' income classification for the rating questions and qualitative conventional content data analysis for the open-ended responses.

RESULTS

A total of 601 participants responded to the survey (49% patients/caregivers and 51% healthcare providers). The highest priority topics identified were diagnostic criteria/classification, bleeding assessment tools and treatment options for women and surgical patients. In contrast, screening for anaemia and differentiating plasma-derived therapy versus recombinant therapies received lower ratings.

CONCLUSION

This survey highlighted areas of importance to a diverse representation of stakeholders in the diagnosis and management of VWD, providing a framework for future guideline development and implementation.

摘要

简介

血管性血友病(VWD)是一种遗传性出血性疾病,由血管性血友病因子的数量或质量功能障碍引起。临床医生、患者和其他利益相关者对该疾病的诊断和管理有许多疑问。

目的

确定对利益相关者最重要的主题,这些主题可以通过美国血液学会(ASH)、国际血栓与止血学会(ISTH)、国家血友病基金会(NHF)和世界血友病联合会(WFH)制定的指南来解决。

方法

一项调查旨在确定并确定在 VWD 指南的协作制定中需要解决的主题的优先级,该调查分发给包括患者、护理人员和医疗保健提供者(HCP)在内的国际利益相关者。四个组织的代表协调了分发策略。该调查侧重于 VWD 的诊断和管理,征求了 7 分李克特量表的答复和英文、法语和西班牙语的开放式回答意见。我们对评分问题进行了描述性分析,并比较了利益相关者类型、性别和国家收入分类的结果,对开放式回答进行了定性常规内容数据分析。

结果

共有 601 名参与者对调查做出了回应(49%的患者/护理人员和 51%的医疗保健提供者)。确定的优先级最高的主题是诊断标准/分类、出血评估工具以及女性和手术患者的治疗选择。相比之下,贫血筛查和区分血浆衍生疗法与重组疗法的评级较低。

结论

这项调查强调了在 VWD 的诊断和管理方面,对不同利益相关者的重要领域,为未来的指南制定和实施提供了框架。

相似文献

1
An international survey to inform priorities for new guidelines on von Willebrand disease.
Haemophilia. 2020 Jan;26(1):106-116. doi: 10.1111/hae.13881. Epub 2019 Nov 26.
2
ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease.
Blood Adv. 2021 Jan 12;5(1):301-325. doi: 10.1182/bloodadvances.2020003264.
3
ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.
Blood Adv. 2021 Jan 12;5(1):280-300. doi: 10.1182/bloodadvances.2020003265.
4
Von Willebrand Disease: Gaining a global perspective.
Haemophilia. 2023 Jul;29(4):1104-1112. doi: 10.1111/hae.14804. Epub 2023 May 22.
7
Reported prevalence of von Willebrand disease worldwide in relation to income classification.
Haemophilia. 2023 Jul;29(4):975-986. doi: 10.1111/hae.14810. Epub 2023 Jun 5.
8
The diagnosis, natural history, and management of von Willebrand disease in women in the age of guidelines.
Expert Rev Hematol. 2023 Jun;16(6):435-450. doi: 10.1080/17474086.2023.2166925. Epub 2023 Jan 12.
9
Diagnosis and management of von Willebrand disease in Spain.
Semin Thromb Hemost. 2011 Jul;37(5):503-10. doi: 10.1055/s-0031-1281036. Epub 2011 Nov 18.
10
Nordic Haemophilia Council's practical guidelines on diagnosis and management of von Willebrand disease.
Semin Thromb Hemost. 2011 Jul;37(5):495-502. doi: 10.1055/s-0031-1281034. Epub 2011 Nov 18.

引用本文的文献

1
Patient-reported data on the severity of Von Willebrand disease.
Haemophilia. 2024 Nov;30(6):1348-1356. doi: 10.1111/hae.15103. Epub 2024 Oct 15.
2
Low von Willebrand factor-unraveling an enigma wrapped in a conundrum.
J Thromb Haemost. 2024 Dec;22(12):3383-3388. doi: 10.1016/j.jtha.2024.08.015. Epub 2024 Sep 10.
4
Burden of Illness and Treatment Patterns Among Patients With von Willebrand Disease in US Clinical Practice.
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231177023. doi: 10.1177/10760296231177023.
8
Hemostatic profile detailing in apparent VWD cases: A cross sectional study.
Saudi J Biol Sci. 2021 Dec;28(12):6701-6704. doi: 10.1016/j.sjbs.2021.07.044. Epub 2021 Jul 19.
10
Surgical management of patients with von Willebrand disease: summary of 2 systematic reviews of the literature.
Blood Adv. 2022 Jan 11;6(1):121-128. doi: 10.1182/bloodadvances.2021005666.

本文引用的文献

1
Recommendations for patient engagement in guideline development panels: A qualitative focus group study of guideline-naïve patients.
PLoS One. 2017 Mar 20;12(3):e0174329. doi: 10.1371/journal.pone.0174329. eCollection 2017.
2
Von Willebrand's Disease.
N Engl J Med. 2017 Feb 16;376(7):701-2. doi: 10.1056/NEJMc1616060.
3
Diagnostic approach to von Willebrand disease.
Blood. 2015 Mar 26;125(13):2029-37. doi: 10.1182/blood-2014-08-528398. Epub 2015 Feb 23.
5
Committee Opinion No.580: von Willebrand disease in women.
Obstet Gynecol. 2013 Dec;122(6):1368-73. doi: 10.1097/01.AOG.0000438961.38979.19.
6
Patients' needs in hematology: whose perspectives?
Haematologica. 2013 Jun;98(6):828-30. doi: 10.3324/haematol.2013.090399.
7
Quality of life in hematology: European Hematology Association theme of the year...and years to come.
Haematologica. 2013 Jan;98(1):2-3. doi: 10.3324/haematol.2012.080796.
9
Von Willebrand disease: local diagnosis and management of a globally distributed bleeding disorder.
Semin Thromb Hemost. 2011 Jul;37(5):440-55. doi: 10.1055/s-0031-1281028. Epub 2011 Nov 18.
10
Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease.
Thromb Haemost. 2011 Nov;106(5):885-92. doi: 10.1160/TH11-03-0180. Epub 2011 Sep 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验